Latest Reports
Anti-retroviral Drug Market
Anti-retroviral Drug Market, By Drug Class (Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Integrase Inhibitors, Entry/Fusion Inhibitors, Others (CCR5 Antagonists, Boosting Agents)), By Drug Combination (Single-Tablet Regimens (STRs), Multi-Tablet Regimens (MTRs), Others (Monotherapies), By Route of Administration (Oral, Parenteral), By Dosage Form (Tablets, Capsules, Oral Solutions/Syrups, Injections, Others (Granules, Powders)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government Agencies, Others (Mail Order Pharmacies)), By End-User (Hospitals, Clinics, Homecare Settings, Others (Research Institutes, Pharmaceutical Companies)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Gilead Sciences, Inc., ViiV Healthcare, Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc
Urinary Tract Infection Treatment Market
Urinary Tract Infection Treatment Market, By Drug Class (Quinolones, Penicillins, Cephalosporins, Aminoglycosides, Others (Fosfomycin, Nitrofurantoin, Trimethoprim-sulfamethoxazole)), By Route of Administration (Oral, Parenteral, Others (Topical, Intravesical)), By Infection Type (Complicated UTIs, Uncomplicated UTIs, Recurrent UTIs, Others (Catheter-associated UTIs, Nosocomial UTIs)), By Pathogen Type (Escherichia coli, Klebsiella pneumoniae, Staphylococcus saprophyticus, Proteus mirabilis, Others (Enterococcus faecalis, Pseudomonas aeruginosa) By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Others (Nursing Homes, Long-term Care Facilities)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Clinics, Mail Order Pharmacies)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Genzyme Corporation, Sanofi S.A, Cadila Healthcare, Mylan N.V.
Patient Registry Software Market
Patient Registry Software Market, By Software Type (Integrated, Standalone), By Delivery Mode (On-premises, Web-based, Cloud-based, Hybrid, Others), By Database Type (Public, Private, Hybrid), By Functionality (Population Health Management, Patient Care Management, Health Information Exchange, Point-of-Care, Product Outcome Evaluation, Disease Reporting, Others), By Pricing Model (Subscription-based, Perpetual Licensing, Usage-based, Freemium), By End-User (Healthcare Providers, Government & Third-Party Administrators, Research Organizations, Pharmaceutical & Biotechnology Companies, Medical Device Companies, Insurance Payers), By Application (Chronic Disease Management, Rare Disease Management, Drug Safety Surveillance, Clinical Trial Recruitment and Management, Post-Marketing Surveillance, Outcome Research, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Quintiles IMS Holdings, Inc. (IQVIA), Optum, Inc., FIGmd, Inc., McKesson Corporation
Hairy Cell Leukemia Market
Hairy Cell Leukemia Market, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplant, Others), By Route of Administration (Oral, Parenteral, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Mechanism of Action (Purine Analog, Monoclonal Antibodies, Kinase Inhibitors, Interferon Therapy, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: AstraZeneca, Novartis, Roche, Bayer, Pfizer, Sanofi, GlaxoSmithKline
Nasopharyngeal Cancer Market
Nasopharyngeal Cancer Market, By Treatment Type (Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others (Surgery, Palliative Care)), By Cancer Type (Keratinizing Squamous Cell Carcinoma, Non-Keratinizing Carcinoma, Undifferentiated Carcinoma, Others (Lymphoepithelioma, Salivary Gland Carcinoma)), By End-User (Hospitals, Specialty Clinics, Cancer Research Centers, Others (Ambulatory Surgical Centers, Home Care Settings)), By Cancer Stage (Stage I, Stage II, Stage III, Stage IV), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Direct Tenders, Specialty Pharmacies)), By Route of Administration (Intravenous, Oral, Others (Intramuscular, Subcutaneous)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., AstraZeneca, Eli Lilly and Company, Sanofi, Novartis, Roche, Pfizer
T-Cell Lymphoma Market
T-Cell Lymphoma Market, By Type (Prefilled Syringe, Injectable, Lyophilized), By Hematopoietic Stem Cell Transplantation Type (Autologous, Allogeneic), By End-user (Hospitals, Specialty Clinics, Stem Cell Banks, Others), By Combination Therapy (Plerixafor + GCSF, Plerixafor + Chemo + GCSF, Others), By Application (Non-Hodgkin's Lymphoma, Multiple Myeloma, Hodgkin's Lymphoma, Acute Myeloid Leukemia, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Gilead Sciences, Novartis, Merck & Co., Bristol-Myers Squibb, Incyte Corporation
Paranasal Sinus Cancer Market
Paranasal Sinus Cancer Market, By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy), By Cancer Type (Maxillary Sinus Cancer, Ethmoid Sinus Cancer, Frontal Sinus Cancer, Sphenoid Sinus Cancer), By End User (Hospitals, Cancer Research Institutes, Ambulatory Surgery Centers), By Stage (Stage I, Stage II, Stage III, Stage IV, Recurrent), By Route of Administration (Injectable, Oral), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Pfizer, AstraZeneca, Bristol-Myers Squibb, Merck, Novartis
Post Cardiac Arrest Syndrome Market
Post Cardiac Arrest Syndrome Market, By Product Type (Therapeutic Hypothermia Systems, Monitoring Devices, Advanced Resuscitation Devices, Diagnostic Equipment, Medications), By End User (Hospitals, Emergency Medical Services, Ambulatory Surgical Centers, Trauma Centers, Long Term Care Centers), By Application (Ventricular Fibrillation, Asystole, Pulseless Electrical Activity), By Patient Group (Adults, Pediatric, Geriatric), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Medtronic, Nihon Kohden, General Electric, Koninklijke Philips, Stryker
Chagas Disease Market
Chagas Disease Market, By Treatment Type (Antiparasitic Medication, Symptomatic and Supportive Treatment, Vaccines, Others (stem cell therapy, gene therapy)), By Diagnostic Test (Microscopic Examination, Molecular Tests (PCR), Immunodiagnostics (ELISA), Others (imaging, cultures)), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, Others (blood banks, NGOs)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Sanofi, Bayer, Abbott, Chemo, Merck, Eisai, Celgene, Insud Pharma, Exeltis, Immune Therapeutics
Diabetic Foot Ulcer Treatment Market
Diabetic Foot Ulcer Treatment Market, By Product Type (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers), By End-User (Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Smith & Nephew, ConvaTec, Coloplast, 3M, Integra LifeSciences , Cardinal Health